Mood disorders - Articles - Page 5

Expert Q&A

Substance-Induced Depression: Diagnosis and Treatment

April 1, 2023

Bryan K. Tolliver, MD, PhD

Associate professor, Addiction Sciences Division, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina. Charleston, SC.

Dr. Tolliver has no financial relationships with companies related to this material.

“When tailoring medication choice, a careful history can guide you. If I’m treating a patient who drinks excessively at night to sleep or who struggles with insomnia when they try to stop drinking, I’ll start with a sedating antidepressant like mirtazapine. That’s not an evidence-based decision, it’s a clinical decision that I think can be helpful.”

Dr. Tolliver gives us a framework to understand the relation between depression, substance use, and substance-induced mood disorders.

CARLAT WEBINAR

Treatment of Bipolar Disorder in Pregnant and Postpartum Women

March 10, 2023

Victoria Hendrick, MD

0.50 CME Credits. What are the risks associated with pharmacologic treatments of bipolar disorder in pregnancy? This webinar will arm clinicians with the knowledge to prescribe (or not to prescribe) during pregnancy.

Research Update

Adjuvant Clonidine for Mania

March 8, 2023

Michael Posternak, MD.

Michael Posternak, MD. Dr. Posternak has no financial relationships with companies related to this material.

Clonidine was a promising therapy for mania in the 1980s, but the ball got dropped. This study picks that up with a modern-day randomized-controlled design.

Expert Q&A

Herbal Therapies for Depression

March 8, 2023

Scott Mendelson, MD, PhD

Scott Mendelson, MD, PhD.

Recently retired after 25 years of practicing inpatient and outpatient psychiatry in community and VA hospitals. He is the author of several psychiatric textbooks including Herbal Treatment of Major Depression (CRC Press, 2019) and Herbal Treatment of Anxiety (CRC Press, 2022).

Dr. Mendelson has no financial relationships with companies related to this material.

Scott Mendelson shows us how to use the top 3 herbal therapies for depression--namely, St. John’s wort, curcumin, and saffron.

Research Update

Top Augmentation Strategies for Treatment-Resistant Depression?

February 1, 2023

Sahil Munjal, MD

Sahil Munjal, MD. Dr. Munjal has no financial relationships with companies related to this material.

This meta-analysis of 69 randomized controlled trials arrives at 9 options for treatment-resistant depression, a few of them controversial.

CARLAT WEBINAR

Frequently Overlooked Considerations in Women's Mental Health

January 10, 2023

Victoria Hendrick, MD

0.50 CME Credits. A summary of some of the current research findings in psychiatric treatment relating to women's mental health.

CLINICAL UPDATE

Viibryd Goes Generic, But Is It Worth Prescribing?

January 1, 2023

Chris Aiken, MD

Chris Aiken, MD. Editor-in-Chief of The Carlat Psychiatry Report. Practicing psychiatrist, Winston-Salem, NC. Dr. Aiken has no financial relationships with companies related to this material.

Goodbye Viibryd, hello vilazodone. This novel medication has missed the mark in a lot of trials, but it still has a narrow niche in the crowded field of antidepressants.

Sorting Out Bipolar Spectrum Disorders in Children and Adolescents

November 28, 2022

Joshua Feder, MD and Mara Goverman

Bipolar disorder is challenging to diagnose in children and adolescents, yet timely and accurate diagnosis is crucial.

Antidepressants and Bipolar at the Mood Summit

November 21, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

Dr. Joe Goldberg gathered the latest evidence on antidepressants in bipolar disorder at the 9th annual Mood Disorders Summit, and we summarize his findings.